UK markets closed

AstraZeneca PLC (AZN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
49.94+0.44 (+0.89%)
At close: 4:00PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5131.37B
Enterprise value 3145.8B
Trailing P/E 41.00
Forward P/E 115.27
PEG ratio (5-yr expected) 11.20
Price/sales (ttm)4.94
Price/book (mrq)8.39
Enterprise value/revenue 35.48
Enterprise value/EBITDA 721.56

Trading information

Stock price history

Beta (5Y monthly) 0.19
52-week change 35.45%
S&P500 52-week change 349.51%
52-week high 364.94
52-week low 345.39
50-day moving average 349.23
200-day moving average 351.69

Share statistics

Avg vol (3-month) 310.75M
Avg vol (10-day) 37.61M
Shares outstanding 52.63B
Implied shares outstanding 6N/A
Float 2.62B
% held by insiders 10.00%
% held by institutions 115.68%
Shares short (14 Mar 2021) 494.94M
Short ratio (14 Mar 2021) 48.15
Short % of float (14 Mar 2021) 4N/A
Short % of shares outstanding (14 Mar 2021) 43.62%
Shares short (prior month 11 Feb 2021) 477.9M

Dividends & splits

Forward annual dividend rate 41.4
Forward annual dividend yield 42.80%
Trailing annual dividend rate 32.80
Trailing annual dividend yield 35.66%
5-year average dividend yield 43.70
Payout ratio 4114.75%
Dividend date 328 Mar 2021
Ex-dividend date 424 Feb 2021
Last split factor 22:1
Last split date 326 Jul 2015

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Dec 2020


Profit margin 12.01%
Operating margin (ttm)15.58%

Management effectiveness

Return on assets (ttm)4.05%
Return on equity (ttm)20.80%

Income statement

Revenue (ttm)26.62B
Revenue per share (ttm)10.14
Quarterly revenue growth (yoy)11.20%
Gross profit (ttm)21.37B
Net income avi to common (ttm)3.2B
Diluted EPS (ttm)1.22
Quarterly earnings growth (yoy)223.30%

Balance sheet

Total cash (mrq)8.03B
Total cash per share (mrq)3.06
Total debt (mrq)22.71B
Total debt/equity (mrq)145.24
Current ratio (mrq)0.96
Book value per share (mrq)5.95

Cash flow statement

Operating cash flow (ttm)4.8B
Levered free cash flow (ttm)3.3B